These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20956339)

  • 1. TIM-3: a novel regulatory molecule of alloimmune activation.
    Boenisch O; D'Addio F; Watanabe T; Elyaman W; Magee CN; Yeung MY; Padera RF; Rodig SJ; Murayama T; Tanaka K; Yuan X; Ueno T; Jurisch A; Mfarrej B; Akiba H; Yagita H; Najafian N
    J Immunol; 2010 Nov; 185(10):5806-19. PubMed ID: 20956339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amelioration of composite tissue allograft rejection by TIM-3-modified dendritic cell: Regulation of the balance of regulatory and effector T cells.
    Wang Y; Zheng Z; Zhu X; Han J; Dong M; Tao K; Wang H; Wang Y; Hu D
    Immunol Lett; 2016 Jan; 169():15-22. PubMed ID: 26561949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells.
    Xiao L; Fu ZR; Liu F; Zhang LD; Shi XM; Shen XY; Ni ZJ; Fu H; Li RD; Cao XT; Ding GS; Wang QX
    PLoS One; 2011; 6(7):e21697. PubMed ID: 21750723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.
    Ueno T; Habicht A; Clarkson MR; Albin MJ; Yamaura K; Boenisch O; Popoola J; Wang Y; Yagita H; Akiba H; Ansari MJ; Yang J; Turka LA; Rothstein DM; Padera RF; Najafian N; Sayegh MH
    J Clin Invest; 2008 Feb; 118(2):742-51. PubMed ID: 18172549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive Transfer of Tracer-Alloreactive CD4
    Miller ML; Chen J; Daniels MD; McKeague MG; Wang Y; Yin D; Vu V; Chong AS; Alegre ML
    Am J Transplant; 2016 Oct; 16(10):2842-2853. PubMed ID: 27063351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.
    Harada H; Salama AD; Sho M; Izawa A; Sandner SE; Ito T; Akiba H; Yagita H; Sharpe AH; Freeman GJ; Sayegh MH
    J Clin Invest; 2003 Jul; 112(2):234-43. PubMed ID: 12865411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
    Gupta S; Thornley TB; Gao W; Larocca R; Turka LA; Kuchroo VK; Strom TB
    J Clin Invest; 2012 Jul; 122(7):2395-404. PubMed ID: 22684103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.
    Yuan X; Paez-Cortez J; Schmitt-Knosalla I; D'Addio F; Mfarrej B; Donnarumma M; Habicht A; Clarkson MR; Iacomini J; Glimcher LH; Sayegh MH; Ansari MJ
    J Exp Med; 2008 Dec; 205(13):3133-44. PubMed ID: 19047438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
    Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
    Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.
    Oikawa T; Kamimura Y; Akiba H; Yagita H; Okumura K; Takahashi H; Zeniya M; Tajiri H; Azuma M
    J Immunol; 2006 Oct; 177(7):4281-7. PubMed ID: 16982862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Yagita H; Turka LA; Sayegh MH
    Am J Transplant; 2005 Jan; 5(1):31-9. PubMed ID: 15636609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease.
    Li X; Chen G; Li Y; Wang R; Wang L; Lin Z; Gao X; Feng J; Ma Y; Shen B; Li Y; Han G
    Clin Immunol; 2010 Feb; 134(2):169-77. PubMed ID: 19913460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.
    Wang F; Wan L; Zhang C; Zheng X; Li J; Chen ZK
    Immunobiology; 2009; 214(5):342-9. PubMed ID: 19362679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.